168 related articles for article (PubMed ID: 37517791)
1. Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD.
Fernández-Sáez EM; Losarcos M; Becerril S; Valentí V; Moncada R; Martín M; Burrell MA; Catalán V; Gómez-Ambrosi J; Mugueta C; Colina I; Silva C; Escalada J; Frühbeck G; Rodríguez A
Metabolism; 2023 Oct; 147():155663. PubMed ID: 37517791
[TBL] [Abstract][Full Text] [Related]
2. Effect of guanylin peptides on pancreas steatosis and function in experimental diet-induced obesity and after bariatric surgery.
Otero A; Becerril S; Martín M; Cienfuegos JA; Valentí V; Moncada R; Catalán V; Gómez-Ambrosi J; Burrell MA; Frühbeck G; Rodríguez A
Front Endocrinol (Lausanne); 2023; 14():1185456. PubMed ID: 37274331
[TBL] [Abstract][Full Text] [Related]
3. High plasma and lingual uroguanylin as potential contributors to changes in food preference after sleeve gastrectomy.
Frühbeck G; Becerril S; Martín M; Ramírez B; Valentí V; Moncada R; Catalán V; Gómez-Ambrosi J; Silva C; Burrell MA; Escalada J; Rodríguez A
Metabolism; 2022 Mar; 128():155119. PubMed ID: 34990711
[TBL] [Abstract][Full Text] [Related]
4. Role of ANGPTL8 in NAFLD Improvement after Bariatric Surgery in Experimental and Human Obesity.
Perdomo CM; Gómez-Ambrosi J; Becerril S; Valentí V; Moncada R; Fernández-Sáez EM; Méndez-Giménez L; Ezquerro S; Catalán V; Silva C; Escalada J; Frühbeck G; Rodríguez A
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884755
[TBL] [Abstract][Full Text] [Related]
5. Guanylin and uroguanylin stimulate lipolysis in human visceral adipocytes.
Rodríguez A; Gómez-Ambrosi J; Catalán V; Ezquerro S; Méndez-Giménez L; Becerril S; Ibáñez P; Vila N; Margall MA; Moncada R; Valentí V; Silva C; Salvador J; Frühbeck G
Int J Obes (Lond); 2016 Sep; 40(9):1405-15. PubMed ID: 27108812
[TBL] [Abstract][Full Text] [Related]
6. Low-Grade Hepatic Steatosis Is Associated with Long-term Remission of Type 2 Diabetes Independent of Type of Bariatric-Metabolic Surgery.
Lautenbach A; Wernecke M; Mann O; Wagner J; Wolter S; Stoll F; Aberle J
Obes Surg; 2023 Feb; 33(2):530-538. PubMed ID: 36508157
[TBL] [Abstract][Full Text] [Related]
7. Antagonic effect of ghrelin and LEAP-2 on hepatic stellate cell activation and liver fibrosis in obesity-associated nonalcoholic fatty liver disease.
Ezquerro S; Tuero C; Becerril S; Valentí V; Moncada R; Landecho MF; Catalán V; Gómez-Ambrosi J; Mocha F; Silva C; Hanley KP; Escalada J; Frühbeck G; Rodríguez A
Eur J Endocrinol; 2023 Jul; 188(7):564-577. PubMed ID: 37358209
[TBL] [Abstract][Full Text] [Related]
8. ACCURACY OF ELASTOGRAPHY IN THE ASSESSMENT OF REDUCTION IN LIVER STEATOSIS AND FIBROSIS IN THE EARLY POSTOPERATIVE PERIOD AFTER BARIATRIC SURGERY.
Lima RR; Garcia JHP; Studart MS; Pinheiro FS; Pinto JOG; Sales LA; Soares LM; Santos PA
Arq Bras Cir Dig; 2022; 35():e1671. PubMed ID: 36043649
[TBL] [Abstract][Full Text] [Related]
9. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
[TBL] [Abstract][Full Text] [Related]
10. Influence of NAFLD and bariatric surgery on hepatic and adipose tissue mitochondrial biogenesis and respiration.
Pedersen JS; Rygg MO; Chrøis K; Sustarsic EG; Gerhart-Hines Z; Wever Albrechtsen NJ; Serizawa RR; Kristiansen VB; Basse AL; Boilesen AEB; Olsen BH; Hansen T; Gluud LL; Madsbad S; Larsen S; Bendtsen F; Dela F
Nat Commun; 2022 May; 13(1):2931. PubMed ID: 35614135
[TBL] [Abstract][Full Text] [Related]
11. Role of ghrelin isoforms in the mitigation of hepatic inflammation, mitochondrial dysfunction, and endoplasmic reticulum stress after bariatric surgery in rats.
Ezquerro S; Becerril S; Tuero C; Méndez-Giménez L; Mocha F; Moncada R; Valentí V; Cienfuegos JA; Catalán V; Gómez-Ambrosi J; Piper Hanley K; Frühbeck G; Rodríguez A
Int J Obes (Lond); 2020 Feb; 44(2):475-487. PubMed ID: 31324878
[TBL] [Abstract][Full Text] [Related]
12. The effects of bariatric surgeries on nonalcoholic fatty liver disease.
Aldoheyan T; Hassanain M; Al-Mulhim A; Al-Sabhan A; Al-Amro S; Bamehriz F; Al-Khalidi H
Surg Endosc; 2017 Mar; 31(3):1142-1147. PubMed ID: 27405478
[TBL] [Abstract][Full Text] [Related]
13. Bariatric surgery for non-alcoholic fatty liver disease in individuals with obesity (Base-NAFLD): protocol of a prospective multicenter observational follow-up study.
Wei L; Li M; Zeng N; Liu Y; Bai R; Zhang N; Song J; Zhang P; Yao Q; Yang Z; Zhao X; Zhang Y; Zhang P; Zhang Z
BMC Surg; 2021 Jun; 21(1):298. PubMed ID: 34167531
[TBL] [Abstract][Full Text] [Related]
14. Effect of bariatric surgery on fatty liver disease in obese patients: A prospective one year follow-up study.
Toman D; Vavra P; Jelinek P; Ostruszka P; Ihnat P; Foltys A; Pelikan A; Roman J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 May; 166(2):195-203. PubMed ID: 33885048
[TBL] [Abstract][Full Text] [Related]
15. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
[TBL] [Abstract][Full Text] [Related]
16. Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score).
von Schönfels W; Beckmann JH; Ahrens M; Hendricks A; Röcken C; Szymczak S; Hampe J; Schafmayer C
Surg Obes Relat Dis; 2018 Oct; 14(10):1607-1616. PubMed ID: 30146425
[TBL] [Abstract][Full Text] [Related]
17. Bariatric Surgery in Nonalcoholic Fatty Liver Disease (NAFLD): Impact Assessment Using Paired Liver Biopsy and Fibroscan.
Agarwal L; Aggarwal S; Shalimar ; Yadav R; Dattagupta S; Garg H; Agarwal S
Obes Surg; 2021 Feb; 31(2):617-626. PubMed ID: 33052552
[TBL] [Abstract][Full Text] [Related]
18. Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis.
Fakhry TK; Mhaskar R; Schwitalla T; Muradova E; Gonzalvo JP; Murr MM
Surg Obes Relat Dis; 2019 Mar; 15(3):502-511. PubMed ID: 30683512
[TBL] [Abstract][Full Text] [Related]
19. Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease.
Cherla DV; Rodriguez NA; Vangoitsenhoven R; Singh T; Mehta N; McCullough AJ; Brethauer SA; Schauer PR; Aminian A
Surg Endosc; 2020 May; 34(5):2266-2272. PubMed ID: 31359195
[TBL] [Abstract][Full Text] [Related]
20. The role of bariatric surgery on beta-cell function and insulin resistance in patients with nonalcoholic fatty liver disease and steatohepatitis.
Poljo A; Kopf S; Sulaj A; Roessler S; Albrecht T; Goeppert B; Bojko S; Müller-Stich BP; Billeter AT
Surg Obes Relat Dis; 2023 Dec; 19(12):1421-1434. PubMed ID: 37666725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
